XRF Scientific has reported a robust September quarter with a 16% increase in revenue, driven by strong international sales and new product launches. The company is poised for further expansion with ongoing innovation and strategic focus on global markets.
- 16% revenue growth to $15.3 million in September quarter
- 7% increase in profit before tax to $3.4 million
- Strong international sales from Canada, Belgium, and Germany
- Growth in capital equipment sales, notably Orbis crushers doubling sales
- Launch of next-generation xrFuse fusion machines and ongoing product development
Solid Quarterly Performance Across Divisions
XRF Scientific Ltd has delivered a strong performance in the September 2025 quarter, reporting a 16% increase in revenue to $15.3 million and a 7% rise in profit before tax to $3.4 million compared to the same period last year. This growth was broad-based, with all divisions contributing positively to the results.
International sales were a key driver, with the company’s offices in Canada, Belgium, and Germany posting robust results. This global footprint is proving critical as XRF leverages demand in diverse markets, offsetting steadier domestic sales. Consumable sales remained steady at $4.4 million, supported by ongoing sample analysis activity in mining production and exploration.
Capital Equipment and Precious Metals Lead Growth
Capital equipment sales rose to $5.0 million from $4.3 million in the prior year quarter, with Orbis crushers standing out by doubling sales to $1.4 million. The Orbis product line continues to gain market share both domestically and internationally, reflecting strong customer adoption. Additionally, incoming orders for other core products like the xrFuse fusion machines improved, signaling healthy demand ahead of the launch of next-generation models scheduled for production in the December quarter.
Precious metals product sales also surged to $5.9 million, up from $4.3 million a year earlier. This segment benefits from a growing recurring revenue base tied to fusion machine installations and platinum labware recycling. Notably, rising platinum prices have increased both revenue and costs, but XRF has managed to maintain steady profit margins by passing through higher costs to customers.
Looking Ahead – Innovation and Expansion
Looking forward, XRF Scientific is optimistic about the December quarter, expecting positive contributions across all divisions. The company is focusing on accelerating international sales growth, advancing new product developments, and exploring merger and acquisition opportunities to bolster its market position. The recent launch of upgraded xrFuse 1 and 2 fusion machines underscores XRF’s commitment to innovation, with additional new products in the pipeline for FY26.
With a global customer base that includes industry heavyweights such as BHP Billiton, Rio Tinto, and Glencore, XRF Scientific’s technology remains integral to improving quality control and process efficiency in mining and industrial sectors worldwide. The company’s strategic emphasis on international expansion and product innovation positions it well to capitalize on evolving market demands.
Bottom Line?
XRF Scientific’s strong quarterly momentum and strategic initiatives set the stage for sustained growth and global market expansion.
Questions in the middle?
- How will rising platinum prices impact XRF’s profitability in the longer term?
- What specific M&A opportunities is XRF targeting to accelerate growth?
- How quickly will the new xrFuse fusion machines penetrate existing and new markets?